In this issue:
LEUKAEMIA SECTION
HLA-C-dependent prevention of leukaemia relapse by donor activating KIR2DS1
Fludarabine+cyclophosphamide+ alemtuzumab in previously untreated CLL
All-trans-retinoic acid, idarubicin and arsenic trioxide in APML
LYMPHOMA SELECTION
MYD88 L265P somatic mutation in WM
Bruton tyrosine kinase inhibition in MM
Up-front autologous SCT in PTCL
6-year Nordic MCL2 trial update
Treating older patients with CML
Pixantrone in relapsed/refractory aggressive NHL
Rabbit ATG and ciclosporin for aplastic anaemia
Please login below to download this issue (PDF)